Format

Send to

Choose Destination

Clostridium botulinum C3 ADP-ribosyltransferase.

Author information

1
Institut für Pharmakologie und Toxikologie, Universität des Saarlandes, Homburg, FRG.

Abstract

C3 and C3-like ADP-ribosyltransferases modify the low-molecular-mass GTP-binding proteins Rho and Rac. ADP-ribosylation occurs in asparagine-41, which is located in the putative effector region of these highly conserved regulatory proteins. First studies indicate that the Rho proteins are somehow involved in the regulation of cytoskeletal proteins, e.g., microfilament proteins. Although the precise mechanism of the interaction of the C3 substrate with cytoskeletal elements is unclear, it appears that the ADP-ribosylation by C3 renders the GTP-binding protein biologically inactive. Thus C3 and/or C3-like ADP-ribosyltransferases may be useful instruments with which to study the physiological functions of its eukaryotic substrates. Moreover, those studies may help to elucidate whether these exoenzymes are of pathophysiological and pathogenetic relevance in diseases caused by clostridia producing these agents.

PMID:
1628497
DOI:
10.1007/978-3-642-76966-5_6
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center